myelin-oligodendrocyte-glycoprotein-(35-55) and cytidylyl-3--5--guanosine

myelin-oligodendrocyte-glycoprotein-(35-55) has been researched along with cytidylyl-3--5--guanosine* in 1 studies

Other Studies

1 other study(ies) available for myelin-oligodendrocyte-glycoprotein-(35-55) and cytidylyl-3--5--guanosine

Article	Year
In vivo administration of TLR9 agonist reduces the severity of experimental autoimmune encephalomyelitis. The role of plasmacytoid dendritic cells and B lymphocytes. CNS neuroscience & therapeutics, 2014, Volume: 20, Issue:8 Topics: Adoptive Transfer; Animals; B-Lymphocytes; CD3 Complex; Dendritic Cells; Dinucleoside Phosphates; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Flow Cytometry; Forkhead Transcription Factors; Mice; Mice, Inbred C57BL; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Toll-Like Receptor 9	2014

Article

Year

In vivo administration of TLR9 agonist reduces the severity of experimental autoimmune encephalomyelitis. The role of plasmacytoid dendritic cells and B lymphocytes.

CNS neuroscience & therapeutics, 2014, Volume: 20, Issue:8

Topics: Adoptive Transfer; Animals; B-Lymphocytes; CD3 Complex; Dendritic Cells; Dinucleoside Phosphates; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Flow Cytometry; Forkhead Transcription Factors; Mice; Mice, Inbred C57BL; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Toll-Like Receptor 9

2014